Early-stage investment – impacts of Covid-19

Our research into the impact of the Covid-19 siutation on innovation-based companies shows that attracting investment and cash-flow are major concerns, based on our survey of Oxfordshire-based businesses.

The Government announced the Future Fund to support risk-capital backed companies on 20th April, 2020.  However, our early assessment suggests that this intervention is unlikely to support early-stage investment (pre-series A level investment) and companies that have not already raised at least £250k will not be eligible.  We are now reaching out to the investment community to gather their views on early-stage investment and the likely impact of Covid-19 on investment activity and decisions.

If you are an investor, please complete a short set of questions to contribute your insights and perspectives.

Click here to add your views

Recent news

Immunocore Wins Prix Galien UK Award for KIMMTRAK

Immunocore Wins Prix Galien UK Award for KIMMTRAK

Immunocore has been awarded a Prix Galien UK award for KIMMTRAK, its treatment for metastatic uveal melanoma- a rare and aggressive form of eye cancer. The Prix Galien UK is one of the highest accolades in the life sciences sector, recognising outstanding innovation...

read more
Business and Trade Committee Launches Two Important Inquiries

Business and Trade Committee Launches Two Important Inquiries

The UK’s Business and Trade Committee has recently announced the launch of two significant inquiries- both of which present crucial opportunities for stakeholders across business, research, and innovation sectors to have their voices heard at a national level. UK...

read more
Loading...